Gastroschisis
What is gastroschisis?
Gastroschisis is a birth defect of the abdominal wall. With this condition the baby’s intestines stick outside of the body through a hole in the abdomen next to the belly button. Gastroschisis occurs early during pregnancy and the hole can be small or large. At times other organs such as the liver and stomach can also be involved. The exposed intestines ad organs can become irritated, swollen, twisted and shortened. It is estimated that 1 in 2,000 babies are born with gastroschisis each year.How is gastroschisis diagnosed?
Gastroschisis can be diagnosed during pregnancy through blood screening and ultrasound. Early detection can assist in safe delivery and intervention after birth. Gastroschisis is seen at the time of birth.What causes gastroschisis?
The exact cause of gastroschisis is unknown. Though it does not appear to be an inherited condition, having a baby born with gastroschisis does seem to make it more likely that another child will be born with this condition. Research is underway to understand the cause.Are there treatment options for gastroschisis?
Treatment for gastroschisis occurs after birth. Treatment cannot occur during pregnancy. Surgery is done very soon after a child is born with gastroschisis. If the opening is small and the intestines that are exposed are not damaged the repair can be done in one step known as a primary repair. If the opening is large and the exposed intestines are swollen the repair must be done in steps known as staged repair. Other treatments include intravenous feeding, infection prevention and close body temperature monitoring. Even with surgical repair, infants can have problems with feeding, digestion, and nutrient absorption.Where can I find more information about gastroschisis?
Gastroschisis Articles

EU Approves Enhertu as First Tumor-Agnostic HER2-Targeted Antibody-Drug Conjugate
Austin Newman
July 27, 2026
Read More »

The Quiet Anger: Processing the Emotional Toll of Chronic Health Conditions
Tom Seaman
July 27, 2026
Read More »

FDA Clears TorEx Lung Perfusion System, Expanding Options for Donor Lung Assessment
Austin Newman
July 27, 2026
Read More »

FDA Issues Final Guidance for Psychedelic Drug Trials, Clarifying Expectations for Developers
Austin Newman
July 26, 2026
Read More »

Alebund Initiates Global Phase IIb Trial of AP306 for Hyperphosphatemia in Hemodialysis Patients
Austin Newman
July 25, 2026
Read More »


Delcath Begins Phase 2 Study of HEPZATO in Liver-Dominant Metastatic Breast Cancer
Austin Newman
July 24, 2026
Read More »

Two of Intellia Therapeutics’ Clinical Trials That Had Been on Hold Have Now Been Released by the FDA
Rose Duesterwald
July 24, 2026
Read More »